ANZINI, MAURIZIO
 Distribuzione geografica
Continente #
NA - Nord America 7.677
EU - Europa 7.241
AS - Asia 1.299
AF - Africa 37
SA - Sud America 15
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 8
Totale 16.287
Nazione #
US - Stati Uniti d'America 7.642
GB - Regno Unito 2.312
IE - Irlanda 1.070
CN - Cina 988
DE - Germania 751
UA - Ucraina 732
SE - Svezia 648
IT - Italia 512
RU - Federazione Russa 407
FR - Francia 381
FI - Finlandia 240
SG - Singapore 201
ES - Italia 54
TR - Turchia 44
CA - Canada 33
RO - Romania 26
CI - Costa d'Avorio 25
BE - Belgio 24
AT - Austria 16
PL - Polonia 16
CZ - Repubblica Ceca 15
IN - India 15
VN - Vietnam 13
BR - Brasile 8
EU - Europa 8
JP - Giappone 8
NL - Olanda 8
EE - Estonia 7
AU - Australia 6
CH - Svizzera 5
IR - Iran 5
LK - Sri Lanka 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
ZA - Sudafrica 4
CL - Cile 3
HK - Hong Kong 3
HU - Ungheria 3
IL - Israele 3
LT - Lituania 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
DK - Danimarca 2
DZ - Algeria 2
EC - Ecuador 2
EG - Egitto 2
GR - Grecia 2
KR - Corea 2
PT - Portogallo 2
AL - Albania 1
BD - Bangladesh 1
BG - Bulgaria 1
CR - Costa Rica 1
CY - Cipro 1
GE - Georgia 1
HR - Croazia 1
KZ - Kazakistan 1
LI - Liechtenstein 1
MN - Mongolia 1
MX - Messico 1
MY - Malesia 1
PE - Perù 1
PY - Paraguay 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 16.287
Città #
Southend 2.124
Fairfield 1.160
Dublin 1.063
Chandler 606
Jacksonville 601
Ashburn 560
Woodbridge 501
Wilmington 477
Santa Clara 450
Seattle 410
Cambridge 390
Houston 387
Ann Arbor 324
Siena 230
Princeton 224
Beijing 219
Nanjing 213
Singapore 142
Menlo Park 123
Helsinki 122
Boardman 102
Munich 102
Fremont 89
Shenyang 67
Nanchang 66
San Diego 64
Shanghai 62
Dearborn 57
Moscow 50
Málaga 48
Lancaster 46
San Mateo 42
Izmir 40
Hebei 39
New York 37
Düsseldorf 36
Tianjin 35
Milan 34
Norwalk 31
Jiaxing 29
Changsha 26
Jinan 26
Abidjan 25
Kunming 25
Venezia 25
Brussels 24
London 24
Redwood City 23
Mestre 22
San Francisco 20
Ningbo 19
Washington 19
Philadelphia 18
Timisoara 17
Zhengzhou 17
Vienna 16
Los Angeles 15
Brno 14
Dong Ket 13
Florence 13
Toronto 13
Hangzhou 12
Rome 11
Gdynia 10
Guangzhou 10
Frankfurt am Main 9
Ottawa 9
Eboli 8
Lanzhou 8
Saint Petersburg 8
Bonndorf 7
Changchun 7
Hefei 7
Montréal 7
Mumbai 7
Taizhou 7
Tallinn 7
Dallas 6
Leawood 6
Amsterdam 5
Edinburgh 5
Fuzhou 5
Stockholm 5
São Paulo 5
Tokyo 5
Auburn Hills 4
Auckland 4
Carmignano 4
Chicago 4
Kilburn 4
Lagos 4
Las Vegas 4
Latina 4
New Bedfont 4
Sala Bolognese 4
West Jordan 4
Bucharest 3
Colombo 3
Durban 3
Grünheide 3
Totale 12.048
Nome #
1,5-Diarylpyrrole-3-acetic Acids and Esters as Novel Classes of Potent and Highly Selective Cyclooxygenase-2 Inhibitors 378
Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside Macrophages 298
Design, Synthesis, and Biological Evaluation of Imidazo[1,5-a]quinoline as Highly Potent Ligands of Central Benzodiazepine Receptors 267
Synthesis and biological evaluation of a new class of benzothiazines as neuroprotective agents 245
Synthesis and Biological Evaluation of Novel Neuroprotective Pyridazine Derivatives as Excitatory Amino Acid Transporter 2 (EAAT2) Activators 244
Aromatase and 5-alpha reductase gene expression: modulation by pain and morphine treatment in male rats 202
Synthesis, biological evaluation and molecular modeling of novel selective COX-2 inhibitors: sulfide, sulfoxide, and sulfone derivatives of 1,5-diarylpyrrol-3-substituted scaffold 200
Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity 194
Carborane-Conjugated 2-Quinolinecarboxamide Ligands of the Translocator Protein for Boron Neutron Capture Therapy 186
Anionic Polymerization of a Benzofulvene Monomer Leading to a Thermoreversible π-Stacked Polymer. Studies in Macromolecular and Aggregate Structure 183
Synthesis and structure-activity relationship studies in serotonin 5-HT4 receptor ligands based on a benzo[de][2,6]naphthridine scaffold 180
Multivalent ligands for the serotonin 5-HT4 receptor 179
Development of subnanomolar-affinity serotonin 5-HT4 receptor ligands based on quinoline structures 179
A Nanocomposite Material Formed by Benzofulvene Polymer Nanoparticles Loaded with a Potent 5-HT3 Receptor Antagonist (CR3124) 176
Physicochemical and biopharmaceutical characterization of endo-2-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-2,3-dihydro-1H-benz[e]isoindol-1-one (CR3124) a novel potent 5-HT3 receptor antagonist 172
Synthesis and structure–activity relationship studies in serotonin 5-HT1A receptor agonists based on fused pyrrolidone scaffolds 170
The Interactions of the 5-HT3 Receptor with Quipazine-Like Arylpiperazine Ligands. The Journey Track at the End of the First Decade of the Third Millennium 168
The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunction 165
Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors 163
Characterization of persistent intramolecular C-H⋅⋅⋅X(N,O) bonds in solid state and solution 162
Nitroesteri di 1,5-Diaril-2-alchil-pirroli-3-sostituiti,Inibitori Selettivi di COX-2 e Donatori di Ossido Nitrico 158
Enlarging the NSAIDs Family: Ether, Ester and Acid Derivatives of the 1,5-Diarrylpyrrole Scaffold as novel anti-inflammatory and analgesic agents 158
Novel Analgesic/Anti-inflammatory Agents: 1,5-Diarylpyrrole Nitrooxyalkyl Ethers and Related Compounds as Cyclooxygenase-2 Inhibiting Nitric Oxide Donors 158
Synthesis, Biological Evaluation, and Quantitative Receptor Docking Simulations of 2-Acylaminoethyl-1,4-benzodiazepines as novel Tifluadom-Like Ligands with High Affinity and Selectivity for k-Opioid Receptors 157
A Non-Peptide NK1 Receptor Agonist Showing Subpicomolar Affinity 155
Phenylindenone isomers as divergent modulators of p38α MAP kinase 155
Characterization of Quinoline Derivatives. II. 7-(4-methyl-1-piperazinyl)-6H-[1]benzopyrano[3,4-c]quinoline 153
Synthesis and Structure-Activity Relationship Studies in Translocator Protein Ligands Based on a Pyrazolo[3,4-b]quinoline Scaffold 153
Antiproliferative effect of two novel COX-2 inhibitors on human keratinocytes 152
Structural Manipulation of Benzofulvene Derivatives Showing Spontaneous Thermoreversible Polymerization. Role of the Substituents in the Modulation of Polymer Properties 151
Bivalent Ligands for the Serotonin 5-HT3 Receptor 151
3-Substituted-1,5-diarly-2-alkyl-pyrroles Highly Selective and Orally Effective COX-2 Inhibitors 151
Dendrimeric tetravalent ligands for the serotonin-gated ion channel 150
Synthesis of trifluoromethyl-substituted pyrazolo[4,3-c]pyridines - Sequential versus multicomponent reaction approach 150
Novel analgesic/anti-inflammatory agents: 1,5-Diarylpyrrole nitrooxyethyl sulfides and related compounds as Cyclooxygenase-2 inhibitors containing a nitric oxide donor moiety endowed with vasorelaxant properties 145
Cyclooxygenase-2 Inhibitors. 1,5-Diarylpyrrol-3-acetic Esters with Enhanced Inhibitory Activity Toward Cyclooxygenase-2 and Improved Cyclooxygenase-2/Cyclooxygenase-1 Selectivity 145
Design, Synthesis, and Biological Evaluation of AT1 Angiotensin II Receptor Antagonists Based on the Pyrazolo[3,4-b]pyridine and related Heteroaromatic Bicyclic Systems 144
Amidine, Thiourea and Guanidine Derivatives of 2-Aminobenzothiazoles and Aminobenzothiazines, Novel Pharmacological Agents for the Treatment of Neurodegenerative Pathologies 143
Novel Analgesic/Anti-inflammatory Agents: Diarylpyrrole Acetic Esters Endowed with Nitric Oxide Releasing Properties 143
A Computational Model of the 5-HT3 Receptor Extracellular Domain: Search for Ligand Binding Sites 141
Synthesis of 1,2,4,-Triazolo[4',3':1,6]pyridazino[4,5-b]quinoline Derivatives 140
Synthesis, Biological Evaluation, and Enzyme Docking Simulations of 1,5-Diarylpyrrole-3-Alkoxyethyl Ethers as Selective Cyclooxygenase-2 Inhibitors Endowed with Anti-inflammatory and Antinociceptive Activity 139
Molecular Basis of Peripheral vs Central Benzodiazepine Receptor Selectivity in a New Class of Peripheral Benzodiazepine Receptor Ligands Related to Alpidem 139
Synthesis of 6,7-Dihydro-8-(4-methyl-1-piperazinyl)-[1]benzoxepino[4,5-c]quinoline as Potential 5-HT3 Receptor Ligand 137
Synthesis and Spontaneous Polymerization of Oligo(ethylene glycol)-Conjugated Benzofulvene Macromonomers. A Polymer Brush Forming a Physical Hydrogel 137
Heterotricyclic Amide Derivatives as Neurokinin-1 (NK1) Receptor Ligands 136
Design, Synthesis, and Structure-Affinity Relationship Studies in NK1 Receptor Ligands Based on Azole-Fused Quinolinecarboxamide Moieties 136
Synthesis, Labeling, and Biological Evaluation of Halogenated 2-Quinolinecarboxamides as Potential Radioligands for the Visualization of Peripheral Benzodiazepine Receptors 135
Development of a CE method for the determination of mycophenolic acid in human plasma: A comparison with HPLC 134
New red-shifted coelenterazine analogues with an extended electronic conjugation 134
Synthesis of 2-Substituted-2,3-dihydro-9-phenyl-1H-pyrrolo[3,4-b]quinolin-3-ones as Potential Peripheral Benzodiazepine-receptor Ligands 133
Further studies on imidazo[4,5-b]pyridine AT1 angiotensin II receptor antagonists. Effects of the transformation of the 4-phenylquinoline backbone into 4-phenylisoquinolinone or 1-phenylindene scaffolds 133
Synthesis of 6-(4-Methyl-1-piperazinyl)-7H-indeno[2,1-c]quinoline Derivatives as Potential 5-HT Receptor Ligands 132
Synthesis and Characterization of a New Benzofulvene Polymer Showing a Thermoreversible Polymerization Behavior 132
Enantioresolution and stereochemical characterization of two chiral sulfoxides endowed with COX-2 inhibitory activity 132
Novel and Highly Potent 5-HT3 Receptor Agonists Based on a Pyrroloquinoxaline Structure 130
Mapping the Peripheral Benzodiazepine Receptor Binding Site by Conformationally Restrained Derivatives of 1-(2-Chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide (PK11195) 129
Synthesis and biological evaluation of amidine, guanidine, and thiourea derivatives of 2-amino(6-trifluoromethoxy)benzothiazole as neuroprotective agents potentially useful in brain diseases 129
Novel Basic Derivatives of Benz[e]isoindol-1-ones and Pyrrolo[3,4-c]quinolin-1-ones with 5-HT3 Antagonistic Activity, their Preparation and their Therapeutic Use 129
5-HT and Benzodiazepine Receptor Ligands. III. Synthesis and Receptor Affinities of 1,2,4,-Triazolo[4',3':1,6]pyridazino[4,5-b]quinoline and 2,3-Dihydro-9-phenyl-1H-pyrrolo[3,4-b]quinoline-1-one Derivatives 128
Polycondensed heterocycles. III. Synthesis of 5,11-dioxo-1,2,3,11a-tetrahydro-5H,11H- and 5-oxo-2,3,11,11a-tetrahydro-1H,5H-pyrrolo[2,1-c][1,4]benzothiazepine 128
Synthesis, in vitro, and in vivo biological evaluation and molecular docking simulations of chiral alcohol and ether derivatives of the 1,5-diarylpyrrole scaffold as novel anti-inflammatory and analgesic agents 127
Structure-Activity Relationships in Carboxamide Derivatives Based on the Targeted Delivery of Radionuclides and Boron Atoms by Means of Peripheral Benzodiazepine Receptor Ligands 126
Design, Synthesis, and Preliminary Biological Evaluation of Pyrrolo[3,4-c]quinolin-1-one and Oxoisoindoline Derivatives as Aggrecanase Inhibitors 126
Characterization of Quinoline Derivatives. I. 6,7-Dihydro-8-(4-methyl-1-piperazinyl)[1]benzoxepino[4,5-c]quinoline 0.13-Hydrate 125
Multivalent Supramolecular Dendrimer-Based Drugs 125
Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety 125
Chondroprotective effect of three different classes of anti-inflammatory agents on human osteoarthritic chondrocytes exposed to IL-1β. S. Cheleschi, N. A. Pascarelli, G. Valacchi, A. Di Capua, M. Biava, G. belmonte, A. Giordani, C. Sticozzi, M. Anzini, A. Fioravanti 125
Synthesis, Resolution, and Absolute Configuration of Two Novel and Selective Cyclooxygenase-2 Inhibitors Based on 1,5-Diarylpyrrole Structure 124
New Insight into the Central Benzodiazepine Receptor-Ligand Interactions: Design, Synthesis, Biological Evaluation, and Molecular Modeling of 3-Substituted 6-Phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and Related Compounds 120
Structure–affinity relationship studies on arylpiperazine derivatives related to quipazine as serotonin transporter ligands. Molecular basis of the selectivity SERT/5-HT3 receptor 120
New π-stacked benzofulvene polymer showing thermoreversible polymerization: studies in macromolecular and aggregate structures and polymerization mechanism 119
Polycondensed heterocycles. VII. A convenient synthesis of pyrrolo[1,2-a]quinoxaline derivatives by intramolecular aromatic nucleophilic displacement 118
Synthesis and structure-activity relationship studies in peripheral benzodiazepine receptor ligands related to alpidem 118
Improving the Solubility of a New Class of Antiinflammatory Pharmacodynamic Hybrids, that Release Nitric Oxide and Inhibit Cycloxygenase-2 Isoenzyme 117
Molecular Structure and Dynamics of Some Potent 5-HT3 Receptor Antagonists. Insight into the Interaction with the Receptor 116
Ethyl 8-Fluoro-6-(3-nitrophenyl)-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate as Novel, Highly Potent, and Safe Antianxiety Agent 113
11C-Labelling of the 5-HT3 Antagonist VC125 for PET Distribution Studies 112
5,6-Dihydro-5-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butyl]-4H- pyrrolo[1,2-a][1,4]benzodiazepine-4,6-dione and Related Compounds as New 5-HT1A Receptor Ligands 112
6-(1-Piperazinyl)-7H-indeno[2,1-c]quinoline Derivatives with High Affinity and Selectivity for 5-HT3 Serotonin Sites 111
Esteri di Acidi Grassi Insaturi e Ormoni Androgeni Potenzialmente utili nel Trattamento del Dolore 111
Characterization and Differentiation of Heterocyclic Isomers. Part 2. Mass Spectrometry and Molecular Orbital Calculations on Pyrrolo[1,2-a][1,4]benzodiazepin-4-one, -6-one, -4,6-dione 110
Hyaluronan graft copolymers bearing fatty-acid residues as self-assembling nanoparticles for olanzapine delivery 110
Further Studies on the Interaction of 5-Hydroxytryptamine3 (5-HT3) Receptor with Arylpiperazine Ligands. Development of a New 5-HT3 Receptor Ligand Showing Potent Acetylcholinesterase Inhibitory Properties 109
Exploring Translocator Protein (TSPO) Medicinal Chemistry: An Approach for Targeting Radionuclides and Boron Atoms to Mitochondria 109
Characterization of Quinoline Derivatives. Part 3. Mass Spectrometry and X-ray Crystallography of Biologically Interesting Arylquinolines 107
Determination of a novel angiotensin-AT1 Antagonist CR3210, in biological samples by HPLC 106
Design, Synthesis, Structural Studies, Biological Evaluation, and Computational Simulations of Novel Potent AT1 Angiotensin II Receptor Antagonists Based on the 4-Phenylquinoline Structure 106
Antiamnestic Effect of the Two Novel k-Opioid Agonists, VA-100 and VA-101, in the Mouse Passive Avoidance Test 105
Synthesis and Biological Characterization of Novel 2-Quinolinecarboxamide Ligands of the Peripheral Benzodiazepine Receptors Bearing Technetium-99m or Rhenium 105
In Vitro Effects of VA441, a New Selective Cyclooxygenase-2 Inhibitor, on Human Osteoarthritic Chondrocytes exposed to IL-1β 105
Mapping and Fitting the Peripheral Benzodiazepine Receptor Binding Site by Carboxamide Derivatives. Comparison of Different Approaches to Quantitative Ligand-Receptor Interaction Modeling 104
Radiosynthesis of [11C]-Labelled COX-2 Selective Inhibitor as a Potential PET Tracer Candidate for Cyclooxigenase-2 Expression 103
Novel polybenzofulvene derivatives: synthesis and uses thereof 100
Synthesis of 6-[N-Alkyl-N-(4-hidroxybutyl)amino]pyrimidine Derivatives- Simplified Analogues of Acyclonucleosides 100
Novel potent 5-HT3 receptor ligands based on the pyrrolidone structure: synthesis, biological evaluation, and computational rationalization of the ligand-receptor interaction modalities 100
Novel Potent and Selective Central 5-HT3 Receptor Ligands Provided with Different Intrinsic Efficacy. 2. Molecular Basis of the Intrinsic Efficacy of Arylpiperazine Derivatives at the Central 5-HT3 Receptors 99
Radiosynthesis and preclinical evaluation of 11C-VA426, a cyclooxygenase-2 selective ligand 97
Novel Potent 5-HT3 Receptor Ligands Based on the Pyrrolidone Structure. Effects of the Quaternization of the Basic Nitrogen on the Interaction with 5-HT3 Receptor 94
Sensitive SPE-HPLC Method to Determine a Novel Angiotensin-AT1 Antagonist in Biological Samples 94
Totale 14.279
Categoria #
all - tutte 51.520
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.520


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.474 0 0 0 0 0 0 252 422 240 282 70 208
2020/20212.348 136 232 49 263 153 341 76 339 306 160 185 108
2021/20221.557 116 220 57 200 64 35 79 47 67 201 147 324
2022/20232.291 136 171 301 344 241 458 50 193 209 64 85 39
2023/20241.583 55 25 186 65 46 438 517 63 0 20 18 150
2024/20251.381 69 174 290 171 395 202 80 0 0 0 0 0
Totale 16.401